Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tozorakimab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease [ID6711]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC